# international edition (audio feeds) — RSS Amplifier Recent posts from the 1 feeds in the RSS Amplifier directory that cover international edition. Page: Feed: --- ## [Postmortem of Rumored AZ-BMS Merger; China as the Bogeyman for US Biopharma's ROI Crisis; Forte Biosciences' Little Known Proxy War](https://asianbiotechiesinabar.substack.com/p/postmortem-of-rumored-az-bms-merger) _2026-08-09 · iSWT Community · iSWT Community_ Asian Biotechies In A Bar; Issue 149; 2026-08-09 ## [“A Fatal Reaction" That is Preventable; Jaw-Dropping TCE Data for Multiple Myeloma; China's PIONEER Program as a New R&D Accelerator](https://asianbiotechiesinabar.substack.com/p/a-fatal-reaction-that-is-preventable) _2026-07-26 · iSWT Community · iSWT Community_ Asian Biotechies In A Bar; Issue 148; 2026-07-06 ## [BioVerse #33 - The West-East Biotech Relay - Accelerating Affordable Innovation](https://asianbiotechiesinabar.substack.com/p/bioverse-33-the-west-east-biotech) _2026-07-14 · iSWT Community · iSWT Community_ A joint webinar with China Pharmaceutical Innovation Conference (CPIC) ## [The Great Rebalancing of Biotech R&D; Biggest Clinical Surprise of 2026 from AstraZeneca & Ionis; Summary of the first China BioPioneers-BioVerse Webinar](https://asianbiotechiesinabar.substack.com/p/the-great-rebalancing-of-biotech) _2026-07-12 · iSWT Community · iSWT Community_ Asian Biotechies In A Bar; Issue 147; 2026-07-12 ## [BioVerse #32 & China BioPioneers International Edition: Innovation, Globalization, and the Next Wave of ADC Development: China–West Perspectives.](https://asianbiotechiesinabar.substack.com/p/bioverse-32-and-china-biopioneers) _2026-07-01 · Jiamin Zhuo · iSWT Community_ We are proud to announce our collaboration with Healthcare Executive, Weijieyao and sponsor Asymchem Group on the inaugural episode of China BioPionners International Edition — a milestone that sits at the heart of our community's mission: bridging the Eastern and Western biopharma worlds to foster deeper understanding and meaningful collaboration. [Listen](https://api.substack.com/feed/podcast/204377083/107d3cfe419e0350e06b90b0f112bd54.mp3) ## [A Trans-Pacific Biotech Relay Model; Pfizer ADC's Phase 3 Flop and A BioTwitter Debate Over a Newco; A Communication Guidebook for Asian Biotechs](https://asianbiotechiesinabar.substack.com/p/pfizer-adcs-phase-3-flop-and-a-biotwitter) _2026-06-28 · iSWT Community · iSWT Community_ Asian Biotechies In A Bar; Issue 146; 2026-06-28 ## [A China CRO Selection Framework for Western Biotechs; Return to Normalcy at the FDA; Recap of the China Biotech panel from SAPA-NE Annual Conference](https://asianbiotechiesinabar.substack.com/p/a-cro-selection-framework-for-western) _2026-06-21 · iSWT Community · iSWT Community_ Asian Biotechies In A Bar; Issue 145; 2026-06-21 ## [Conversation with Eli Lilly's Top Deal-Maker; Recap of Biotech Deal-Making Panel; Tango's Latest PRMT5 Data](https://asianbiotechiesinabar.substack.com/p/conversation-with-eli-lillys-top) _2026-06-14 · iSWT Community · iSWT Community_ Asian Biotechies In A Bar; Issue 144; 2026-06-14 ## [BioVerse #31 - ASCO & ADA 2026 Recap - Asian Biotech On the Rise](https://asianbiotechiesinabar.substack.com/p/asco-and-ada-2026-recap-asian-biotech) _2026-06-11 · iSWT Community · iSWT Community_ BioVerse - Where Science Sparks Business in Medicines ## [Divergent Reception of China-Only Data from Akeso and Legend; Post-Daraxonrasib Landscape of KRAS](https://asianbiotechiesinabar.substack.com/p/divergent-reception-of-china-only) _2026-06-07 · iSWT Community · iSWT Community_ Asian Biotechies In A Bar; Issue 143; 2026-06-07 ## [Marketplace for AI-Powered Professionals (Sponsored)](https://crawlproof.com/a/InoKOdXWoYuH) _2026-06-07 · **Sponsored**_ Find professionals who use ChatGPT, Copilot, and Claude to deliver work faster. ## [Pfizer-Innovent $10.5-billion deal & China biotech moments at ASCO 2026; The untold Kelun story behind its SAC-TMT](https://asianbiotechiesinabar.substack.com/p/the-untold-kelun-story-behind-its) _2026-05-31 · iSWT Community · iSWT Community_ Asian Biotechies In A Bar; Issue 142; 2026-05-31 ## [Memorial Day Weekend Listening & Reading; Boston Chapter Career Developemnet Event; ASCO 2026 Networking](https://asianbiotechiesinabar.substack.com/p/memorial-day-weekend-listening-and) _2026-05-24 · iSWT Community · iSWT Community_ Asian Biotechies In A Bar; Issue 141; 2026-05-24 ## [Lessons from Neurona's $1.15B Exit; Reflections on UChicago China Forum; A Clean Slate of FDA Leadership](https://asianbiotechiesinabar.substack.com/p/lessons-from-neuronas-115b-exit-reflections) _2026-05-17 · iSWT Community · iSWT Community_ Asian Biotechies In A Bar; Issue 140; 2026-05-17 ## [How Candid Therapeutics Leveraged Clinical Trials in China for a $2.2-Billion Acquisition; Marty Makary Allegedly Being Fired; Next-Gen CDK to Watch at ASCO](https://asianbiotechiesinabar.substack.com/p/marty-makary-allegedly-being-fired) _2026-05-10 · iSWT Community · iSWT Community_ Issue 139; 2026-05-10 ## [Sun Pharma to Acquire Organon for $11.75 Bn; A Bad Week for China Biotech; US and Europe's Diverging Attitudes toward China Biotech](https://asianbiotechiesinabar.substack.com/p/sun-pharma-to-acquire-organon-for) _2026-05-03 · iSWT Community · iSWT Community_ Issue 138; 2026-05-03 ## [BioVerse #30 - Recap of AACR2026 - ADC, (K)RAS, Synthetic Lethality, Immuno-Oncology, New Drugs, and AI](https://asianbiotechiesinabar.substack.com/p/bioverse-30-recap-of-aacr2026-adc) _2026-04-29 · iSWT Community · iSWT Community_ BioVerse #30 ## [China to Close Drug Pricing Gap; PD-1xVEGF & TROP2 Preview at ASCO; Three Near-Deaths and One 70x Return Behind Kelonia's $7-Billion Acquisition](https://asianbiotechiesinabar.substack.com/p/china-to-close-drug-pricing-gap-preview) _2026-04-26 · iSWT Community · iSWT Community_ Issue 137; 2026-04-26 ## [RAS is On; China Newco After Kailera's IPO Success](https://asianbiotechiesinabar.substack.com/p/ras-is-on-china-newco-after-kaileras) _2026-04-19 · iSWT Community · iSWT Community_ Issue 136; 2026-04-19 ## [FDA Answers to China's IIT; Biotech's "Three-Body Problem"; Breaking In, Moving Up - A Career Tip for East Asian Biopharma Exe](https://asianbiotechiesinabar.substack.com/p/fda-answers-to-chinas-iit-biotechs) _2026-04-12 · iSWT Community · iSWT Community_ Issue 135; 2026-04-12 ## [Reach prospects with real signals (Sponsored)](https://crawlproof.com/a/zWddpFY7ZBwH) _2026-04-12 · **Sponsored**_ Find prospects talking about your problem and get context-backed moments to engage ## [Western Companies' New China Strategies; Why MFN Matters to Asian Biotech; Decode The New Tariffs for Patented Pharmaceuticals](https://asianbiotechiesinabar.substack.com/p/western-companies-new-china-strategies) _2026-04-05 · iSWT Community · iSWT Community_ Issue 134; 2026-04-05